Parexel launches new clinical trial management system

By Melissa Fassbender contact

- Last updated on GMT

Parexel launches new clinical trial management system

Related tags: Clinical trial management, Pharmaceutical industry, Clinical trial, Pharmacology

Parexel says pharmaceutical companies could start managing their clinical trials in as little as four weeks with new system.

The US CRO claims the IMPACT Express Clinical Trial Management System (CTMS) offers a new way for small to mid-sized biopharmaceutical companies to manage clinical trials and monitoring – One of the most expensive steps in the drug development process.

“Conducting clinical trials is a complex, challenging series of tasks that involves generating and consolidating data from many sources, coordinating numerous functions, and making timely informed decisions​,” Patrick Nadolny, VP of Product Management, Data and Analytics Services, PAREXEL Informatics told Outsourcing-pharma.com.

Biopharmaceuticals companies can save time and money by applying integrated processes and data driven approaches to trial management and monitoring according to Nadolny, who said the firm's new technology simplifies the process, in addition to improving patient safety oversight and regulatory compliance.

Nadolny said the platform promotes “robust clinical trial management from a single, easy-to-use implement, hosted solution​” adding that capabilitiesinclude oversight, trial tracking, site monitoring, investigator management and selection, as well as payment management.

Industry forecast

When asked what could be expected from the industry in the next five years, Nadolny said advancements in patient centric technology, which will be critical in successfully developing cost effective medicines.

We see many examples of technological devices used in academic and clinical trial settings as an exciting trend towards mHealth​,” he adds. “It is also important to note that clinical trials generate an increasing volume of data that requires new approaches to data integration and analysis​.”

According to Nadolny, drug companies will need to re-engineer their technology platform and corresponding processes to extract the right information to drive real-time decision making.

With the IMPACT Express CTMS, the company is also including a training program and expects pharmaceutical and biopharmaceutical companies to be able to start managing their clinical trials in as little as four weeks.

Related news

Show more

Related products

show more

What should a clinical metadata repository do?

What should a clinical metadata repository do?

Formedix | 26-Jul-2021 | Technical / White Paper

Choosing a clinical metadata repository (MDR) software can be a tough task as the capabilities and features of your chosen MDR could make or break your...

Adapting supply chains to new ways of working

Adapting supply chains to new ways of working

World Courier | 15-Jul-2021 | Technical / White Paper

COVID-19 has changed the way we operate. We have adapted our supply chain solutions to meet our clients’ requirements while following World Courier standard...

Empowering Clinical Trial Sponsors with Analytics

Empowering Clinical Trial Sponsors with Analytics

PerkinElmer | 14-Jul-2021 | Technical / White Paper

Is your Clinical Data Review creating problems or solving them? Take Control of Your Data. PerkinElmer Informatics Clinical Solutions, powered by Tibco...

What are the building blocks of DCTs?

What are the building blocks of DCTs?

Medable | 26-Apr-2021 | Technical / White Paper

How to create a seamless experience across eConsent, eCOA and more.

Over the past year, tremendous progress was made toward digitizing and...

Related suppliers

Follow us

Products

View more

Webinars